Table 2.

Most Common Clinical Conditions Associated With Cannabis-Attributable Visits, by Route of Exposure

Condition	Edible Exposure (n = 238), n (%)	Inhalable Exposure (n = 2329), n (%)	Absolute Difference (Edible — Inhalable) (95% CI), percentage points	Total Visits, n (%)
Gastrointestinal symptoms	36(15.1)	752 (32.3)	−17.2 (−12.2 to −22.1)	788 (30.7)
Cannabinoid hyperemesis syndrome	20 (8.4)	420(18.0)	−9.6 (−5.7 to −13.5)	440 (17.1)
Intoxication	115(48.3)	647 (27.8)	20.5 (13.9 to 27.1)	762 (29.7)
Psychiatric symptoms	62 (26.1)	571 (24.5)	1.6 (−4.2 to 7.4)	633 (24.7)
Acute psychiatric symptoms	43(18.0)	254(10.9)	7.1 (2.1 to 12.1)	297 (46.9)
Acute exacerbation of underlying chronic disease	1 (0.4)	93 (4.0)	−3.6 (−2.5 to −4.7)	94(14.1)
Chronic psychiatric condition	1 (0.4)	99 (4.3)	−3.9 (−2.8 to −5.0)	100 (15.8)
Cardiovascular symptoms	19(8.0)	73(3.1)	4.9 (1.4 to 8.4)	92 (3.6)